All time low
QUINCE THERAPEUTICS (QNCX): 0.6132 -11.83%
52w: 0.6118 – 14.600
Total Cash (mrq) 94.34M
Total Cash Per Share (mrq) 2.61
Total Debt (mrq) 420k
Book Value Per Share (mrq) 2.89
Shares Outstanding 36.13M
Float 27.61M
Shares Short (Nov 14, 2022) 4 3.38M
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
